As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...

Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend ...

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, November 7, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company ...

Ethiopia has launched the national introduction of the Hepatitis B Birth Dose (HepB BD) vaccine, marking a major step in strengthening newborn immunization and combating the transmission of Hepatitis ...

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious ...

Diagnosed with hepatitis B about eight years ago and now in the cirrhosis stage (liver damage), the 49-year-old from Sabah admitted that he was initially disheartened before finding the strength to ...

Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.

One initiative, a call for increasing hepatitis B screening in pregnant women, could have immediate vaccine policy ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial. ECLIPSE MedPage ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in ...